The tablets may not dissolve properly in the body, potentially making the medication less effective than intended ...

More than 11,000 bottles of a commonly prescribed blood pressure medication have been recalled because the tablets may not ...

Mumbai-based manufacturer Inventia Healthcare Limited recalled the prescription-only Chlorthalidone Tablets USP, 25 mg on June 5 due to "failed dissolution specifications." ...

The FDA initiated the recall on June 5, and thousands of prescriptions have been recalled since ...

The FDA recalled a common blood pressure medication after quality concerns, prompting patients nationwide to check their bottles.

Over 11,000 bottles of chlorthalidone blood pressure medication are being recalled nationwide due to failed dissolution specifications, according to the FDA.

The U.S. Food and Drug Administration has announced a nationwide recall of thousands of bottles of a commonly prescribed blood pressure medication after testing revealed a potential problem that could ...

The FDA has initiated a recall of over 11,000 bottles of Chlorthalidone Tablets USP, 25 mg, due to concerns about their effectiveness.

Thousands of bottles of a popular blood pressure medication have been recalled nationwide due to a potential manufacturing issue that may affect how well the drug works. According to the U.S. Food and ...

CHICAGO, IL—Chlorthalidone does not reduce major adverse cardiovascular events compared hydrochlorothiazide in older, predominantly male military veterans with hypertension, according to the ...

May 24, 2011 (New York, New York) — The use of the combination therapy azilsartan medoxomil (Edarbi, Takeda Pharmaceuticals) and chlorthalidone resulted in a more effective reduction in systolic blood ...

WEST CONSHOHOCKEN, Pa., Nov. 7, 2025 /PRNewswire/ -- PRM Pharma, LLC announces the nationwide availability of HemiClor® (chlorthalidone) 12.5 mg tablets, the first and only FDA-approved 12.5 mg ...